NWR iPSCs were differentiated into cardiomyocytes using a human kit (PSC Cardiomyocyte Differentiation Kit:Gibco), using the supplied protocol. In brief, feeder-free iPSCs were plated at a density of 6,400–7,900 cells/cm2 on Geltrex in mTeSR1. The use of Rho kinase (ROCK) inhibitors was not necessary for cell survival during plating. Successful wells achieved ∼20% confluency on the first day of differentiation, slightly less than the minimum of the range of 30%–90%. Medium was changed every other day, and cells began to contract ∼9 days after the start of differentiation.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.